Your browser doesn't support javascript.
loading
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
Rugo, Hope S; Im, Seock-Ah; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D; Bachelot, Thomas; Wright, Gail S; Saura, Cristina; Escrivá-de-Romaní, Santiago; De Laurentiis, Michelino; Schwartz, Gary N; Pluard, Timothy J; Ricci, Francesco; Gwin, William R; Levy, Christelle; Brown-Glaberman, Ursa; Ferrero, Jean-Marc; de Boer, Maaike; Kim, Sung-Bae; Petráková, Katarína; Yardley, Denise A; Freedman, Orit; Jakobsen, Erik H; Gal-Yam, Einav Nili; Yerushalmi, Rinat; Fasching, Peter A; Kaufman, Peter A; Ashley, Emily J; Perez-Olle, Raul; Hong, Shengyan; Rosales, Minori Koshiji; Gradishar, William J.
Afiliación
  • Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
  • Im SA; Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
  • Cortes J; Quironsalud Group, International Breast Cancer Center (IBCC), Madrid and Barcelona, Spain.
  • Curigliano G; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.
  • Musolino A; Istituto Europeo di Oncologia, IRCCS, University of Milano, Milan, Italy.
  • Pegram MD; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Bachelot T; Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
  • Wright GS; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy.
  • Saura C; Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Stanford, CA.
  • Escrivá-de-Romaní S; Medical Oncology Department, Centre Leon Berard, Lyon, France.
  • De Laurentiis M; Florida Cancer Specialists & Research Institute, New Port Richey, FL.
  • Schwartz GN; Medical Oncology Service, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Pluard TJ; Medical Oncology Service, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Ricci F; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione Pascale," Naples, Italy.
  • Gwin WR; Division of Medical Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Levy C; Saint Luke's Cancer Institute, Kansas City, MO.
  • Brown-Glaberman U; Institut Curie, Paris, France.
  • Ferrero JM; Division of Medical Oncology/Seattle Cancer Care Alliance, University of Washington, Seattle, WA.
  • de Boer M; Centre François Baclesse, Institut Normand du Sein, Caen, France.
  • Kim SB; Division of Hematology/Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
  • Petráková K; Department of Medical Oncology, Centre Antoine Lacassagne, University Côte d'Azur, Nice, France.
  • Yardley DA; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, GROW-School of Oncology and Developmental Biology, Maastricht, the Netherlands.
  • Freedman O; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Jakobsen EH; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Gal-Yam EN; Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, TN.
  • Yerushalmi R; RS McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, ON, Canada.
  • Fasching PA; Department of Oncology, Vejle Hospital, Vejle, Denmark.
  • Kaufman PA; Chaim Sheba Medical Center, Breast Oncology Institute, Ramat Gan, Israel.
  • Ashley EJ; Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
  • Perez-Olle R; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Hong S; Breast Oncology, Division of Hematology/Oncology, University of Vermont Cancer Center, Burlington, VT.
  • Rosales MK; MacroGenics, Inc, Rockville, MD.
  • Gradishar WJ; MacroGenics, Inc, Rockville, MD.
J Clin Oncol ; 41(2): 198-205, 2023 01 10.
Article en En | MEDLINE | ID: mdl-36332179
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá